Results 71 to 80 of about 5,534,172 (226)

Long‐Term Survival Following Nivolumab Treatment in Pulmonary Tumour Thrombotic Microangiopathy Associated With Cancer of Unknown Primary: A Case Report

Respirology Case Reports, Volume 14, Issue 10, October 2026.
Pulmonary tumour thrombotic microangiopathy (PTTM) is a rapidly fatal condition that is rarely diagnosed during life. Early clinical recognition and prompt nivolumab treatment resulted in long‐term survival in a patient with cancer of unknown primary‐associated PTTM.
Kosuke Fujishima, Jun Osugi, Satoshi Noma, Mitsunori Higuchi, Hiroyuki Suzuki   +4 more
wiley   +1 more source

Regional and temporal changes in AIDS in Europe before HAART [PDF]

, 2002
In a prospective observational study 4485 patients from 46 clinical centres in 17 European countries were followed between April 1994 and November 1996.
Fätkenheuer, G., Phillips, AN, Vanhems, P, Parkin, J. M., Phillips, A.N., Ben-Ishai, Z., Kirk, O., EuroSIDA Study Grp, E, Blaxhult, A,, Fox, Z, Fatkenheuer, G, Blaxhult, A., Kirk, O, Blaxhult, A, Parkin, JM, Francioli, P, Colebunders, R., F\ue4tkenheuer, G., Phillips, A. N., Francioli, P., Vanhems, P., Parkin, J.M., Colebunders, R, Fox, Z., Ben-Ishai, Z   +24 more
core   +1 more source

Minimum inhibitory concentration (MIC) values for 13 drugs tested against the Mycobacterium avium complex clinical isolates.

, 2023
Minimum inhibitory concentration (MIC) values for 13 drugs tested against the Mycobacterium avium complex clinical isolates.
Auttawit Sirichoat (9033704), Yothin Hinwan (17442200), Orawee Kaewprasert (9931459), Kiatichai Faksri (775893)   +3 more
core   +1 more source

Nerandomilast‐Associated Pneumonitis With a Positive Rechallenge: A Case Report

Respirology Case Reports, Volume 14, Issue 10, October 2026.
Nerandomilast was associated with new bilateral pulmonary opacities and inflammatory deterioration 9 days after treatment initiation in a woman with advanced interstitial lung disease. Withdrawal led to improvement, whereas reduced‐dose re‐exposure was followed by recurrence the next day and repeated improvement after discontinuation.
Toyoshi Yanagihara, Eriko Kinoshita, Yuuka Sakaki, Yuko Fujino, Masaki Fujita   +4 more
wiley   +1 more source

General statistics and features of the whole-genome sequences of 38 Mycobacterium avium complex clinical isolates.

, 2023
General statistics and features of the whole-genome sequences of 38 Mycobacterium avium complex clinical isolates.
Auttawit Sirichoat (9033704), Yothin Hinwan (17442200), Orawee Kaewprasert (9931459), Kiatichai Faksri (775893)   +3 more
core   +1 more source

Mycobacterium intracellulare M.i.198—A Promising Strain for Studying Pathogenesis of Nontuberculous Mycobacterial Pulmonary Disease (NTM‐PD)

Microbiology and Immunology, Volume 70, Issue 10, Page 493-503, October 2026.
ABSTRACT In this review, we introduce a promising strain for studying pathogenesis of nontuberculous mycobacterial pulmonary disease (NTM‐PD), Mycobacterium intracellulare M.i.198. M.i.198 was isolated from a patient with progressive Mycobacterium avium‐intracellulare complex pulmonary disease (MAC‐PD) in whom surgical operation was required to ...
Yoshitaka Tateishi, Ryoji Maekura, Yukiko Nishiuchi, Sohkichi Matsumoto   +3 more
wiley   +1 more source

Helicobacter pylori In Free‐Living Amoebae: A Potential Environmental Reservoir for Persistence and Transmission

Environmental Microbiology Reports, Volume 18, Issue 5, October 2026.
Free‐living amoebae may provide an underrecognised environmental niche for Helicobacter pylori, supporting its intracellular persistence, morphological plasticity, and protection from environmental stress. These interactions could facilitate prolonged survival in aquatic and food‐associated environments and contribute to potential waterborne or ...
Otmane Lamrabet, Meriem Bekliz, Shamsul Qumar, Merylin Sebastian, Ula Abdurahman, Mohamad Hamad, Lucy Semerjian, Ghalia Khoder   +7 more
wiley   +1 more source

Minimum inhibitory concentration (MIC) distributions of 13 drugs tested against 38 clinical isolates of Mycobacterium avium complex species.

, 2023
Minimum inhibitory concentration (MIC) distributions of 13 drugs tested against 38 clinical isolates of Mycobacterium avium complex species.
Auttawit Sirichoat (9033704), Yothin Hinwan (17442200), Orawee Kaewprasert (9931459), Kiatichai Faksri (775893)   +3 more
core   +1 more source

Liposomal Glutathione Exhibits Direct and Intracellular Antimycobacterial Activity Against Mycobacterium avium via Membrane Depolarization in a THP-1 Macrophage Model

Bioengineering
Mycobacterium avium (M. avium) is an opportunistic intracellular pathogen causing chronic pulmonary disease in immunocompromised individuals, particularly in those with HIV/AIDS.
Nezam Newman, Kayvan Sasaninia, Wajiha Akif, Kaylee Dillard, Destiny Jaime, Kaitlyn Nguyen, Malina Navarrette, Jesse Melendez, Iffat Hasnin Era, Ama Xu, Navya Sharma, Syed Muzzammil Ahmad, Rakesh Kumar Tiwari, Vishwanath Venketaraman   +13 more
doaj   +1 more source

A case report of disseminated Mycobacterium colombiense infection in an HIV patient

International Journal of Mycobacteriology, 2019
Mycobacterium colombiense is a newly recognized member of the Mycobacterium avium complex, and only a few cases of infections caused by this pathogen have been reported. We present an imported case of disseminated disease caused by M.
Eduarda Pena, Diana Machado, Miguel Viveiros, Sofia Jordão   +3 more
doaj   +1 more source